Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload
Titel:
Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload
Auteur:
Nolte, F. Höchsmann, B. Giagounidis, A. Lübbert, M. Platzbecker, U. Haase, D. Lück, A. Gattermann, N. Taupitz, M. Baier, M. Leismann, O. Junkes, A. Schumann, C. Hofmann, W. K. Schrezenmeier, H.